| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032340167 |
| P356 | DOI | 10.1007/S00467-012-2206-9 |
| P698 | PubMed publication ID | 22763847 |
| P2093 | author name string | Hakan R Toka | |
| Ali Hariri | |||
| Jacob M Koshy | |||
| P2860 | cites work | Linkage analysis in the next-generation sequencing era | Q24289003 |
| Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter | Q24311551 | ||
| Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2 | Q24313292 | ||
| Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I | Q24315663 | ||
| Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III | Q24317311 | ||
| Rare independent mutations in renal salt handling genes contribute to blood pressure variation | Q24627187 | ||
| Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk | Q24630394 | ||
| Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects | Q27693302 | ||
| Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy | Q28140188 | ||
| Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase | Q28208090 | ||
| Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion | Q28209314 | ||
| Human hypertension caused by mutations in WNK kinases | Q28212182 | ||
| Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel | Q28240272 | ||
| Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1 | Q28275138 | ||
| Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome | Q28288744 | ||
| Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase | Q28297160 | ||
| Global burden of hypertension: analysis of worldwide data | Q28302545 | ||
| 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess | Q28303737 | ||
| A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group | Q28307394 | ||
| KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function | Q28506527 | ||
| Genome-wide association study of blood pressure and hypertension | Q28943443 | ||
| Genome-wide association study identifies eight loci associated with blood pressure | Q29614414 | ||
| Molecular mechanisms of human hypertension | Q32138445 | ||
| Hereditary Brachydactyly Associated with Hypertension | Q33585733 | ||
| Monogenic forms of human hypertension | Q34118168 | ||
| Blood pressure control--special role of the kidneys and body fluids | Q34126033 | ||
| Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma | Q34142563 | ||
| The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results | Q34236470 | ||
| Trafficking and cell surface stability of ENaC. | Q34335739 | ||
| A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. | Q34551734 | ||
| Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians | Q35172107 | ||
| Bartter syndrome | Q35200486 | ||
| Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities | Q35754537 | ||
| Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. | Q35787055 | ||
| WNK kinases: molecular regulators of integrated epithelial ion transport | Q35858400 | ||
| K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension | Q36019674 | ||
| Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas | Q36831552 | ||
| A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism | Q36834983 | ||
| Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. | Q37130485 | ||
| Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure | Q37148149 | ||
| Renin-angiotensin system in kidney development: renal tubular dysgenesis | Q37634952 | ||
| Genetic testing in renal disease | Q37880653 | ||
| Under pressure: the search for the essential mechanisms of hypertension | Q37953776 | ||
| Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetes. | Q37965851 | ||
| Inversion region for hypertension and brachydactyly on chromosome 12p features multiple splicing and noncoding RNA. | Q38458980 | ||
| Invited Review Recognition and management of angiotensin converting enzyme inhibitor fetopathy | Q40458815 | ||
| Severely impaired baroreflex-buffering in patients with monogenic hypertension and neurovascular contact | Q42496275 | ||
| Inherited renal tubular dysgenesis may not be universally fatal | Q42980141 | ||
| A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients | Q43565017 | ||
| Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density | Q44055170 | ||
| Hypertension and Severe Hyperkalaemia Associated with Suppression of Renin and Aldosterone and Completely Reversed by Dietary Sodium Restriction | Q45163111 | ||
| Neurovascular compression at the ventrolateral medulla in autosomal dominant hypertension and brachydactyly | Q48626109 | ||
| Time course of inner ear degeneration and deafness in mice lacking the Kir4.1 potassium channel subunit. | Q50484599 | ||
| Congenital adrenal hyperplasia. | Q52010571 | ||
| Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. | Q52217431 | ||
| Disruption of Na+,HCO₃⁻ cotransporter NBCn1 (slc4a7) inhibits NO-mediated vasorelaxation, smooth muscle Ca²⁺ sensitivity, and hypertension development in mice. | Q52616732 | ||
| Demographic, dietary, life style, and anthropometric correlates of blood pressure. | Q52716479 | ||
| Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension. | Q53003916 | ||
| Medical treatment of classic and nonclassic congenital adrenal hyperplasia. | Q53419377 | ||
| Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null mice. | Q53861199 | ||
| Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. | Q54535930 | ||
| High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR. | Q54569451 | ||
| A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension | Q55671192 | ||
| A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly | Q56982819 | ||
| Maternal component in the familial aggregation of hypertension | Q57282162 | ||
| Maternal influence on blood pressure suggests involvement of mitochondrial DNA in the pathogenesis of hypertension: the Framingham Heart Study | Q57308692 | ||
| Cardiovascular risk factors in a french canadian population: Resolution of genetic and familial environmental effects on blood pressure using twins, adoptees, and extensive information on environmental correlates | Q57316028 | ||
| Functional Characterization of a Calcium-Sensing Receptor Mutation in Severe Autosomal Dominant Hypocalcemia with a Bartter-Like Syndrome | Q63979939 | ||
| Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK | Q71614570 | ||
| Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule | Q72666321 | ||
| Families with autosomal dominant brachydactyly type E, short stature, and severe hypertension | Q77060899 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 387-399 | |
| P577 | publication date | 2012-07-05 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | The molecular basis of blood pressure variation | |
| P478 | volume | 28 |
| Q38263731 | An update on the pharmacogenetics of treating hypertension. |
| Q28272095 | Epithelial sodium channel (ENaC) family: Phylogeny, structure-function, tissue distribution, and associated inherited diseases |
| Q38287281 | Gordon Syndrome: a continuing story |
| Q37658904 | Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci |
| Q26825557 | New functional aspects of the extracellular calcium-sensing receptor |
| Q38292348 | Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways. |
| Q91646718 | The Molecular Genetics of Gordon Syndrome |
| Q88648846 | Vitamin D and Calcimimetics in Cardiovascular Disease |
Search more.